Premier Research vs Tigermed

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/premier-research/tigermedgrp

Category	Premier Research	Tigermed
Listed site	cro	cro
Summary	Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.	Leading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Data Management & eClinical Biostatistics & Statistical Programming Medical Writing Pharmacovigilance & Drug Safety Central Laboratory Services Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Translational Research GLP Toxicology Safety Pharmacology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Device & Combination Product Services	Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Clinical Trial Services Clinical Imaging Core Lab Central Laboratory Services Medical Writing Pharmacovigilance & Drug Safety Biostatistics & Statistical Programming Data Management & eClinical Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy China NMPA Regulatory Strategy Japan PMDA Regulatory Strategy Device & Combination Product Services Translational Research GLP Toxicology In Vitro ADME / DMPK In Vitro Pharmacology Preclinical In Vitro Studies In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Medicinal Chemistry High-Throughput Screening Oncology Specialty Services Cardiovascular & Metabolic Specialty Services CNS Specialty Services Immunology & Inflammation Services Virology Services Microbiology Services
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine Peptide	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Vaccine Cell Therapy Gene Therapy Radiopharmaceutical Oligonucleotide Peptide
Indications	Oncology Immunology Neurology Infectious Disease Rare Disease Dermatology Women's Health	Oncology Cardiovascular Neurology Immunology Infectious Disease Rare Disease Metabolic Ophthalmology Gastroenterology Respiratory
Locations	Headquarters, Morrisville, NC, United States Southbank, Southbank, VIC, Australia Sofia, Sofia, Bulgaria Toronto, Mississauga, ON, Canada Prague, Praha, Czech Republic Paris, Paris, France Darmstadt, Darmstadt, Germany Budapest, Budapest, Hungary Bengaluru, Bengaluru, India Auckland, Auckland, New Zealand Warsaw, Warszawa, Poland Bucharest, Bucharest, Romania Bratislava, Bratislava, Slovakia Seoul, Seoul, South Korea Madrid, Madrid, Spain Taipei, Taipei, Taiwan Kyiv, Kyiv, Ukraine Wokingham, Wokingham, Berkshire, United Kingdom	Headquarters, Hangzhou, Zhejiang, China Global Offices, Multiple, Global, Multiple (180+ locations across 5 continents)
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.